The Biden administration is putting pharmaceutical companies on notice. Washington is warning them that if the price of certain drugs is too high, the government might cancel their patent protection and allow rivals to make their own versions.
If you develop drugs using tax payer money, then that has to be paid back in some way. Either as a percentage of profits (based on percentage invested), paying back the investment (with interest) or an agreement on a cheaper price. Or something else.
Pharma has had it’s cake and eating it for far too long.
Nothing that is being suggested is unreasonable here.
If you develop drugs using tax payer money, then that has to be paid back in some way. Either as a percentage of profits (based on percentage invested), paying back the investment (with interest) or an agreement on a cheaper price. Or something else.
Pharma has had it’s cake and eating it for far too long.
Nothing that is being suggested is unreasonable here.